Paul V. Effler

35 Stirling Highway
Perth, WA 6009, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 96 publications

Impact and effectiveness of Australia's 2025 hybrid RSV immunisation program: results from the PAEDS-FluCAN Network.

Impact and effectiveness of Australia's 2025 hybrid RSV immunisation program: results from the PAEDS-FluCAN Network.

Journal: The Lancet regional health. Western Pacific

Published: March 05, 2026

What is the optimal RSV immunisation strategy for infants born in the RSV off-season?

What is the optimal RSV immunisation strategy for infants born in the RSV off-season?

Journal: The Journal of infectious diseases

Published: March 04, 2026

Post-licensure safety monitoring of nirsevimab in Western Australia 2024.

Post-licensure safety monitoring of nirsevimab in Western Australia 2024.

Journal: Vaccine

Published: December 18, 2025

Clinical, psychological and quality of life outcomes up to 12-months following thrombosis with thrombocytopenia syndrome after ChAdOx1-S (AZD1222) vaccination in Australia.

Clinical, psychological and quality of life outcomes up to 12-months following thrombosis with thrombocytopenia syndrome after ChAdOx1-S (AZD1222) vaccination in Australia.

Journal: Vaccine

Published: December 17, 2025

Twenty-four years of response: an analysis of Global Outbreak Alert and Response Network deployments to and from the WHO Western Pacific Region.

Twenty-four years of response: an analysis of Global Outbreak Alert and Response Network deployments to and from the WHO Western Pacific Region.

Journal: Western Pacific surveillance and response journal : WPSAR

Published: November 10, 2025

Factors associated with persistence or recovery from long COVID 6 months post-SARS-CoV-2 infection.

Factors associated with persistence or recovery from long COVID 6 months post-SARS-CoV-2 infection.

Journal: Epidemiology and infection

Published: September 18, 2025

Seasonality and regional variation of respiratory syncytial virus-associated hospital admissions in northern Western Australia, 2012-2023.

Seasonality and regional variation of respiratory syncytial virus-associated hospital admissions in northern Western Australia, 2012-2023.

Journal: Australian and New Zealand journal of public health

Published: August 28, 2025

More evidence needed for maternal RSVpreF protection to age 6 months.

More evidence needed for maternal RSVpreF protection to age 6 months.

Journal: The Lancet. Infectious diseases

Published: May 20, 2025

Respiratory Syncytial Virus Strain Evolution and Mutations in Western Australia in the Context of Nirsevimab Prophylaxis.

Respiratory Syncytial Virus Strain Evolution and Mutations in Western Australia in the Context of Nirsevimab Prophylaxis.

Journal: Open forum infectious diseases

Published: April 08, 2025

Surveillance and follow up outcomes of myocarditis after mRNA COVID-19 vaccination in Australia.

Surveillance and follow up outcomes of myocarditis after mRNA COVID-19 vaccination in Australia.

Journal: NPJ vaccines

Published: February 13, 2025

Nirsevimab immunisation of infants and respiratory syncytial virus (RSV)-associated hospitalisations, Western Australia, 2024: a population-based analysis.

Nirsevimab immunisation of infants and respiratory syncytial virus (RSV)-associated hospitalisations, Western Australia, 2024: a population-based analysis.

Journal: The Medical journal of Australia

Published: January 26, 2025

ACTIVE POST-MARKETING SAFETY SURVEILLANCE OF NIRSEVIMAB ADMINISTERED TO CHILDREN IN WESTERN AUSTRALIA, APRIL-JULY 2024.

ACTIVE POST-MARKETING SAFETY SURVEILLANCE OF NIRSEVIMAB ADMINISTERED TO CHILDREN IN WESTERN AUSTRALIA, APRIL-JULY 2024.

Journal: The Pediatric infectious disease journal

Published: January 08, 2025

Showing 1-12 of 96

Last Updated: 09/26/2026